Multitargeted therapy of cancer by lycopene

Cancer Letters

Volumn 269, Issue 2, 2008, Pages 339-351

  van Breemen, Richard B ^a   Pajkovic, Natasa ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Carotenoid; Chemoprevention; Iycopene; Natural product; Prostate cancer

Indexed keywords

ALPHA CAROTENE; BETA CAROTENE; CAROTENOID; FREE RADICAL; GROWTH FACTOR; LYCOPENE; OXYGEN; PLATELET DERIVED GROWTH FACTOR BB;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; BLADDER CANCER; CANCER INVASION; CANCER RISK; CANCER THERAPY; CELL CYCLE ARREST; CELL NUCLEUS; CHEMOPROPHYLAXIS; COLORECTAL CANCER; GRAPEFRUIT; GUAVA; HUMAN; ISOMERIZATION; METASTASIS; NONHUMAN; PAPAYA; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY; SIGNAL TRANSDUCTION; TOMATO; WATERMELON;

CARICA PAPAYA; CITRULLUS LANATUS VAR. LANATUS; CITRUS X PARADISI; LYCOPERSICON ESCULENTUM; PSIDIUM;

EID: 51349149762     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.05.016     Document Type: Review

References (87)

1. Straub O. Lists of natural carotenoids. In: Pfander H., and Basel H. (Eds). Key to Carotenoids (1987), Verlag, Birkhauser
2. Olson J.A., and Krinsky N.I. Introduction: the colorful, fascinating world of the carotenoids: important physiologic modulators. FASEB J. 9 (1995) 1547-1550
3. Miller E.S., Mackinney G., and Zscheile Jr. F.P. Absorption spectra of alpha and beta carotenes and lycopene. Plant Physiol. (1935) 375-381
4. Clinton S.K. Lycopene: chemistry, biology, and implications for human health and disease. Nutr. Rev. 56 (1998) 35-51
5. Tonucci L.H., Holden J.M., Beecher G., Khachik F., Davis C.S., and Mulokozi G. Carotenoid content of thermally processed tomato-based food products. J. Agric. Food Chem. 43 (1995) 579-586
6. Bohm V., Frohlich K., and Bitsch R. Rosehip - a "new" source of lycopene. Mol. Aspects Med. 24 (2003) 385-389
7. Mangels A.R., Holden J.M., Beecher G.R., Forman M.R., and Lanza E. Carotenoid content of fruits and vegetables: an evaluation of analytic data. J. Am. Diet. Assoc. 93 (1993) 284-296
8. Stahl W., Schwarz W., Sundquist A.R., and Sies H. Cis-trans isomers of lycopene and beta-carotene in human serum and tissues. Arch. Biochem. Biophys. 294 (1992) 173-177
9. Krinsky N.I. The antioxidant and biological properties of the carotenoids. Ann. N. Y. Acad. Sci. 854 (1998) 443-447
10. Fang L., Pajkovic N., Wang Y., Gu C., and van Breemen R.B. Quantitative analysis of lycopene isomers in human plasma using high-performance liquid chromatography-tandem mass spectrometry. Anal. Chem. 75 (2003) 812-817
11. Henry L.K., Pspitasari-Nienaber N.L., Jaren-Galan J., van Breemen R.B., Catignani G.I., and Schwartz S.J. Effects of ozone and oxygen on the degradation of carotenoids in an aqueous model system. J. Agric. Food. Chem. 48 (2000) 5008-50013
12. Armstrong G., and Hearst J. Carotenoids 2: genetics and molecular biology of carotenoid pigment biosynthesis. FASEB J. 10 (1966) 228-237
13. Demmig-Adams B., Gilmore A., and Adams W. Carotenoids 3: in vivo function of carotenoids in higher plants. FASEB J. 10 (1996) 403-412
14. Wiseman H., and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in infammatory disease and progression to cancer. Biochem. J. 313 (1996) 17-29
15. Huang H.Y., Helzlsouer K.J., and Appel L.J. The effects of vitamin C and vitamin E on oxidative DNA damage: results from a randomized controlled trial. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 647-652
16. Frelon S., Douki T., Favier A., and Cadet J. Hydroxyl radical is not the main reactive species involved in the degradation of DNA bases by copper in the presence of hydrogen peroxide. Chem. Res. Toxicol. 16 (2003) 191-197
17. Britton G. Carotenoids 1: structure and properties of carotenoids in relation to function. FASEB J. 9 (1995) 1551-1558
18. Di Mascio P., Kaiser S., and Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys. 274 (1989) 532-538
19. Krinsky N.I. Mechanism of action of biological antioxidants. Proc. Soc. Exp. Biol. Med. 200 (1992) 248-254
20. Krinsky N.I. Overview of lycopene, carotenoids, and disease prevention. Proc. Soc. Exp. Biol. Med. 218 (1988) 95-97
21. Ukai N., Lu Y., and Etoh H. Photosensitized oxygenation of lycopene. Biosci. Biotechnol. Biochem. 58 (1994) 1718-1719
22. Bast A., Haenen G.R., van den Berg R., and van den Berg H. Antioxidant effects of carotenoids. Int. J. Vitam. Nutr. Res. 68 (1998) 399-403
23. Muzandu K., Ishizuka M., Sakamoto K.Q., Shaban Z., El Bohi K., Kazusaka A., and Fujita S. Effect of lycopene and beta-carotene on peroxynitrite-mediated cellular modifications. Toxicol. Appl. Pharmacol. 215 (2006) 330-340
24. Muzandu K., El Bohi K., Shaban Z., Ishizuka M., Kazusaka A., and Fujika S. Lycopene and beta-carotene ameliorate catechol estrogen-mediated DNA damage. Jpn. J. Vet. Res. 52 (2005) 173-184
25. Park Y.O., Hwang E.S., and Moon T.W. The effect of lycopene on cell growth and oxidative DNA damage of Hep3B human hepatoma cells. Biofactors 23 (2005) 129-139
26. Liu A., Pajkovic N., Pang Y., Zhu D., Calamini B., Mesecar A.L., and van Breemen R.B. Absorption and subcellular localization of lycopene in human prostate cancer cells. Mol. Cancer Ther. 5 (2006) 2879-2885
27. Ben-Dor A., Steiner M., Gheber L., Danilenko M., Dubi N., Linnewiel K., Zick A., Sharoni Y., and Levy J. Carotenoids activate the antioxidant response element transcription system. Mol. Cancer Ther. 4 (2005) 177-186
28. Goo Y.A., Li Z., Pajkovic N., Shaffer S., Taylor G., Chen J., Campbell D., Arnstein L., Goodlett D.R., and van Breemen R.B. Systematic investigation of lycopene effects in LNCaP cells by use of novel large-scale proteomic analysis software. Proteomics Clin. Appl. 1 (2007) 513-523
29. Hantz H.L., Young L.F., and Martin K.R. Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Exp. Biol. Med. 230 (2005) 171-179 (Maywood)
30. Chen L., Stacewicz-Sapuntzakis M., Duncan C., Sharifi R., Ghosh L., van Breemen R., Ashton D., and Bowen P.E. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J. Natl. Cancer Inst. 93 (2001) 1872-1879
31. Ivanov N.I., Cowell S.P., Brown P., Rennie P.S., Guns E.S., and Cox M.E. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clin. Nutr. 26 (2007) 252-263
32. Kanagaraj P., Vijayababu M.R., Ravisankar B., Anbalagan J., Aruldhas M.M., and Arunakaran J. Effect of lycopene on insulin-like growth factor-I, IGF binding protein-3 and IGF type-1 receptor in prostate cancer cells. J. Cancer Res. Clin. Oncol. 133 (2007) 351-359
33. Salman H., Bergman M., Djaldetti M., and Bessler H. Lycopene affects proliferation and apoptosis of four malignant cell lines. Biomed. Pharmacother. 61 (2007) 366-369
34. Diehl J.A. Cycling to cancer with cyclin D1. Cancer Biol. Ther. 1 (2003) 226-231
35. Nahum A., Zeller L., Danilenko M., Prall O.W., Watts C.K., Sutherland R.L., Levy J., and Sharoni Y. Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. Eur. J. Cancer 45 (2006) 275-282
36. Matsushima-Nishiwaki R., Shidoji Y., Nishiwaki S., Yamada T., Moriwaki H., and Muto Y. Suppression by carotenoids of microcystin-induced morphological changes in mouse hepatocytes. Lipids 30 (1995) 1029-1034
37. Lian F., Smith D.E., Russell R.M., and Wang X.D. apo-10′-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 28 (2007) 1567-1574
38. Fornelli F., Leone A., Verdesca I., Minervini F., and Zacheo G. The influence of lycopene on the proliferation of human breast cell line (MCF-7). Toxicol. In Vitro 21 (2007) 217-223
39. Gunasekera R.S., Sewgobind K., Desai S., Dunn L., Black H.S., McKeehan W.L., and Patil B. Lycopene and lutein inhibit proliferation in rat prostate carcinoma cells. Nutr. Cancer 58 (2007) 171-177
40. Barber N.J., Zhang X., Zhu G., Pramanik R., Barber J.A., Martin F.L., Morris J.D., and Muir G.H. Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study. Prostate Cancer Prostatic Dis. 9 (2006) 407-413
41. Heldin C.H., and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79 (1999) 1283-1316
42. Ruiter D., Bogenrieder T., Elder D., and Herlyn M. Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol. 3 (2002) 35-43
43. Chiang H.S., Wu W.B., Fang J.Y., Chen D.F., Chen B.H., Huang C.C., Chen Y.T., and Hung C.F. Lycopene inhibits PDGF-BB-induced signalling and migration in human dermal fibroblasts through interaction with PDF-BB. Life Sci. 81 (2007) 1509-1517
44. Hwang E.S., and Lee H.J. Inhibitory effects of lycopene on the adhesion, invasion, and migration of SK-Hep1 human hepatoma cells. Exp. Biol. Med. 231 (2006) 322-327 (Maywood)
45. Huang C.S., Fan Y.E., Lin C.Y., and Hu M.L. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. J. Nutr. Biochem. 18 (2007) 449-456
46. Huang C.S., Shih M.K., Chuang C.H., and Hu M.L. Lycopene inhibits cell migration and invasion and upregulates nm23-h1 in a highly invasive hepatocarcinoma, SK-Hep-1 cells. J. Nutr. 135 (2005) 2119-2123
47. Xu X., Wang Y., Constantinou A.I., Stacewicz-Sapuntzakis M., Bowen P.E., and van Breemen R.B. Solubilization and stabilization of carotenoids using micelles: delivery of lycopene to cells in culture. Lipids 34 (1999) 1031-1036
48. Cooney R.V., Kappock T.J., Pung A., and Bertram J.S. Solubilization, cellular uptake and activity of β-carotene and other carotenoids as inhibitors of neoplastic transformation in cultured cells. Methods Enzymol. 214 (1993) 55-68
49. O'Sullivan S.M., Woods J.A., and O'Brien N.M. Use of Tween 40 and Tween 80 to deliver a mixture of phytochemicals to human colonic adenocarcinoma cell (CaCo-2) monolayers. Br. J. Nutr. 91 (2004) 757-764
50. Lin C.Y., Huang C.S., and Hu M.L. The use of fetal bovine serum as delivery vehicle to improve the uptake and stability of lycopene in cell culture studies. Br. J. Nutr. 98 (2007) 226-232
51. Lingen C., Ernster L., and Lindberg O. The promoting effect of lycopene on the non-specific resistance of animals. Exp. Cell. Res. 16 (1959) 384-393
52. Forssberg A., Lingen C., Ernster L., and Lindberg O. Modification of the x-irradiation syndrome by lycopene. Exp. Cell. Res. 16 (1959) 7-14
53. Tang L., Jin T., Zeng X., and Wang J.S. Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J. Nutr. 135 (2005) 287-290
54. Limpens J., Schröder F.H., de Ridder C.M., Bolder C.A., Wildhagen M.F., Obermüller-Jevic U.C., Krämer K., and van Weerden W.M. Combined lycopene and vitamin E treatment suppresses the growth of PC-346C human prostate cancer cells in nude mice. J. Nutr. 136 (2006) 1287-1293
55. Siler U., Herzog A., Spitzer V., Seifert N., Denelavas A., Buchwald Hunziker P., Barella L., Huziker W., Lein M., Goralczyk R., and Wertz K. Lycopene effects on rat normal prostate and prostate tumor tissue. J. Nutr. 135 (2005) 2050S-2052S
56. Nagasawa H., Mitamura T., Sakamoto S., and Yamamoto K. Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice. Anticancer Res. 15 (1995) 1173-1178
57. Sharoni Y., Giron E., Rise M., and Levy J. Effects of lycopene-enriched tomato oleoresin on 7,12-dimethyl-ben[a]anthracene-induced rat mammary tumors. Cancer Detect. Prev. 21 (1997) 118-123
58. Kim D.J., Takasuka N., Kim J.M., Sekine K., Ota T., Asamoto M., Murakoshi M., Nishino H., Nir Z., and Tsuda H. Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. Cancer Lett. 120 (1997) 15-22
59. Watanabe S., Kitade Y., Masaki T., Nishioka M., Satoh K., and Nishino H. Effects of lycopene and Sho-saiko-to on hepatocarcinogenesis in a rat model of spontaneous liver cancer. Nutr. Cancer 39 (2001) 96-101
60. Liu C., Russell R.M., and Wang X.D. Lycopene supplementation prevents smoke-induced changes in p53, p53phosphorylation, cell proliferation, and apoptosis in the gastric mucosa of ferrets. J. Nutr. 136 (2006) 106-111
61. Gitanay D., Lyan B., Rambeau M., Mazur A., and Rock E. Comparison of lycopene and tomato effects on biomarkers of oxidative stress in vitamin E deficient rats. Eur. J. Nutr. 46 (2007) 468-475
62. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J. Natl. Cancer Inst. 99 (1999) 317-331
63. Mills P.K., Beeson W.L., Phillips R.L., and Fraser G.E. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 64 (1989) 598-604
64. Giovannucci E. A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp. Biol. Med. 227 (2002) 852-859 (Maywood)
65. Fleshner N.E., and Klotz L.H. Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev. 17 (1998) 325-330
66. Giovannucci E., Ascherio A., Rimm E.B., Stampfer M.J., Colditz G.A., and Willett W.C. Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst. 87 (1995) 1767-1776
67. Giovannucci E., and Clinton S.K. Tomatoes, lycopene, and prostate cancer. Proc. Soc. Exp. Biol. Med. 218 (1998) 129-139
68. Giovannucci E., Rimm E.B., Liu Y., Stampfer M.J., and Willett W.C. A prospective study of tomato products, lycopene, and prostate cancer. J. Natl. Cancer Inst. 94 (2002) 391-398
69. Kirsh V.A., Mayne S.T., Peters U., Chatterjee N., Leitzmann M.F., Dixon L.B., Urban D.A., Crawford E.D., and Hayes R.B. A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 92-98
70. Peters U., Leitzmann M.F., Chatterjee N., Wang Y., Albanes D., Gelmann E.P., Friesen M.D., Riboli E., and Hayes R.B. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 962-968
71. Maserejian N.N., Giovannucci E., Rosner B., and Joshipura K. Prospective study of vitamins C, E, and A and carotenoids and risk of oral premalignant lesions in men. Int. J. Cancer 120 (2007) 970-977
72. Michaud D.S., Spiegelman D., Clinton S.K., Rimm E.B., Willett W.C., and Giovannucci E.L. Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J. Natl. Cancer Inst. 91 (1999) 605-613
73. Männistö S., Yuan S.S., Hunter D.J., Spiegelman D., Adami H.O., Albanes D., van den Brandt P.A., Buring J.E., Cerhan J.R., Colditz G.A., Freudenheim J.L., Fuchs C.S., Giovannucci E., Goldbohm R.A., Harnack L., Leitzmann M., McCullough M.L., Miller A.B., Rohan T.E., Schatzkin A., Virtamo J., Willett W.C., Wolk A., Zhang S.M., and Smith-Warner S.A. Dietary carotenoids and risk of colorectal cancer in a pooled analysis of 11 cohort studies. Am. J. Epidemiol. 165 (2007) 246-255
74. Kucuk O., Sarkar F.H., Sakr W., Djuric Z., Pollak M.N., Khachik F., Li Y.W., Banerjee M., Grignon D., Bertram J.S., Crissman J.D., Pontes E.J., and Wood Jr. D.P. Cancer epidemiol. Biomarkers Prev. 10 (2001) 861-868
75. Clark P.E., Hall M.C., Borden Jr. L.S., Miller A.A., Hu J.J., Lee W.R., Stindt D., D'Agostino Jr. R., Lovato J., Harmon M., and Torti F.M. Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology 67 (2006) 1257-1261
76. Bunker C.H., McDonald A.C., Evans R.W., de la Rosa N., Boumosleh J.M., and Patrick A.L. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutr. Cancer. 57 (2007) 130-137
77. Jatoi A., Burch P., Hillman D., Vanyo J.M., Dakhil S., Nikcevich D., Rowland K., Morton R., Flynn P.J., Young C., and Tan W. North Central Cancer Treatment Group, A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology 69 (2007) 289-294
78. van Breemen R.B. How do intermediate endpoint markers respond to lycopene in men with prostate cancer or benign prostate hyperplasia. J. Nutr. 135 (2005) 2062S-2064S
79. Erdman Jr. J.W., Bierer T.L., and Gugger E.T. Absorption and transport of carotenoids. In: Olson J.A. (Ed). Carotenoids in human health (1993), New York Academy of Sciences, New York 76-85
80. Stahl W., and Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J. Nutr. 122 (1992) 2161-2166
81. Parker R.S. Absorption, transport and metabolism of carotenoids. FASEB J. 10 (1996) 542-5451
82. Gustin D.M., Rodvold K.A., Sosman J.A., Diwadkar-Navsariwala V., Stacewicz-Sapuntzakis M., Viana M., Crowell J.A., Murray J., Tiller P., and Bowen P.E. Single-dose pharmacokinetic study of lycopene delivered in a well-defined food-based lycopene delivery system (tomato paste-oil mixture) in healthy adult male subjects. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 850-860
83. van Breemen R.B., Xu X., Viana M.A., Chen L., Stacewicz-Sapuntzakis M., Duncan C., Bowen P.E., and Sharifi R. Liquid chromatography-mass spectrometry of cis- and all-trans-lycopene in human serum and prostate tissue after dietary supplementation with tomato sauce. J. Agric. Food Chem. 50 (2002) 2214-2219
84. Zaripheh S., and Erdman Jr. J.W. The biodistribution of a single oral dose of [14C]-lycopene in rats prefed either a control or lycopene-rich diet. J. Nutr. 135 (2005) 2212-2218
85. Khachik F., Carvalho L., Bernstein P.S., Muir G.J., Zhao D.Y., and Katz N.B. Chemisitry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp. Biol. Med. 227 (2002) 845-851 (Maywood)
86. Gajic M., Zaripheh S., Sun F., and Erdman Jr. J.W. Apo-8′-lycopenal and apo-12′-lycopenal are metabolic products of lycopene in rat liver. J. Nutr. 136 (2006) 1552-1557
87. Hu K.Q., Liu C., Hansgeorg E., Krinsky N.I., Russell R.M., and Wang X.D. The biochemical characterization of ferret carotene-9′-10′-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. J. Biol. Chem. 281 (2006) 19327-19338